Generix Laboratories
Aggressive Thermogenic Compound
Serving
1 Capsule(s)
Per container
60
Form
capsule-unknown
UPC
896025000206
DSLD
Formula hash
a651372362cc
Brand context
Catalog
2
products
With avoid flag
2
products
FDA recalls
0
history
CAERS
0
reports
Avoid-flaggedObjective label signals
Flagged excipients
3
1 avoid · 2 caution
FDA recalls
0
no recall history
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
8 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| BiphedAdrene 2(TM) Proprietary Blend (Combination)other | 489 mg | — |
| Ilex paraguariensis (leaf) Extract MateherbUNII · 1Q953B4O4F | 0 NP | — |
| Guarana Seed Extract GuaranaherbUNII · 52U584F1CA | 0 NP | — |
| Methylxanthine CaffeineherbUNII · E9M81NJM6G | 0 NP | — |
| Turnera diffusa var. Aphrodisiaca (leaf) Extract DamianaherbUNII · 812R0W1I3K | 0 NP | — |
| Capsaicin herbUNII · S07O44R1ZM | 0 NP | — |
| Seratonin herb | 0 NP | — |
| L-Dopa L-DOPAherb | 0 NP | — |
Flagged excipients
3 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
- ◐ CAUTIONFD&C Yellow #5color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
- ◐ CAUTIONFD&C Yellow #6color
EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.
Other ingredients
Gelatin · Rice Flour · Stearic Acid · Magnesium Stearate · Silicon Dioxide